Association between changes in oestradiol and follicle‐stimulating hormone levels during the menopausal transition and risk of diabetes

To investigate the association between changes in oestradiol and follicle‐stimulating hormone levels during the menopausal transition and incident diabetes.

We followed 1407 pre‐menopausal women, aged 42–52 years at baseline, who experienced natural menopause, from baseline to the 12^th annual follow‐up visit in the Study of Women's Health Across the Nation (SWAN). Diabetes was defined based on fasting glucose level, medication use and self‐report of physician diagnosis. Cox proportional hazards regression was used to evaluate the associations of incident diabetes with three components of the rate of change in hormones: the intercept (pre‐menopausal levels) and two piece‐wise slopes representing change during the early and late transition, respectively.

During 15 years of follow‐up, 132 women developed diabetes. After adjusting for potential confounders, a higher oestradiol intercept, but not its rate of change, was borderline significantly associated with lower risk of diabetes [hazard ratio for an interquartile range increase (75.2 pmol/L) 0.53, 95% CI 0.27–1.06]. For follicle‐stimulating hormone, a greater rate of increase in the early transition, but not the intercept or late transition, was significantly associated with lower risk of diabetes [hazard ratio for an interquartile range increase (5.9 IU/L/year) 0.31, 95% CI 0.10–0.94].

Lower pre‐menopausal oestradiol levels and a slower rate of follicle‐stimulating hormone change during the early transition were associated with higher risk of developing diabetes. Given that obesity plays an important role in diabetes risk and in the levels and changes in oestradiol and follicle‐stimulating hormone over the menopausal transition, weight control in earlier mid‐life is important to prevent future diabetes development.